CompletedPhase 2NCT04357730
Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection
Studying Severe acute respiratory syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Denver Health and Hospital Authority
- Principal Investigator
- Ernest E Moore, MDDenver Health Medical Center (DHMC)
- Intervention
- Alteplase 50 MG [Activase](drug)
- Enrollment
- 50 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2020 – 2021
Study locations (9)
- Scripps Memorial Hospital La Jolla, La Jolla, California, United States
- University of Colorado, Denver, Aurora, Colorado, United States
- Denver Health Medical Center, Denver, Colorado, United States
- National Jewish Health, Denver, Colorado, United States
- St. Mary's Medical Center, West Palm Beach, Florida, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- Long Island Jewish Medical Center, New York, New York, United States
- Methodist Dallas Medical Center, Dallas, Texas, United States
- Ben Taub Hospital, Houston, Texas, United States
Collaborators
Genentech, Inc. · University of Colorado, Denver · National Jewish Health · Beth Israel Deaconess Medical Center · Long Island Jewish Medical Center · Scripps Health · St. Mary's Medical Center · University of Miami · Ben Taub Hospital · The Methodist Hospital Research Institute
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04357730 on ClinicalTrials.govOther trials for Severe acute respiratory syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06099795Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2Centre Hospitalier Universitaire de Nīmes
- RECRUITINGPHASE4NCT06585241A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine FormulationsModernaTX, Inc.
- RECRUITINGNCT06168019Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in IndiaBoston University
- RECRUITINGEARLY PHASE1NCT05656105Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) InfectionUniversity of Alabama at Birmingham
- RECRUITINGNCT05892549COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern CharacteristicsDirection Centrale du Service de Santé des Armées
- RECRUITINGNANCT05566483Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional CapacityUniversity of Colorado, Denver
- ACTIVE NOT RECRUITINGNCT05787964Immunity to Infection in Healthy Participants and Participants With CancerUniversity Hospital Tuebingen
- RECRUITINGPHASE2, PHASE3NCT05543616A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy ChildrenBioNTech SE